Serina Therapeutics (SER)
Develops long-acting drug conjugates through its POZ polymer platform.
$2.65
Pre-market−0.05 (−1.85%)
At close$2.70(+8.00%)
Something off on this page? Send us feedback.
Next report
Nov 18, 2026
estimated · in 76 days
EPS estimate
−$0.34
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.27−$0.49−$0.66−$0.45−$0.31−$0.58−$0.55Pending
Estimate$0.42−$0.62−$0.36−$0.47−$0.50−$0.44−$0.47−$0.34
Surprise−164.3%+21.0%−83.3%+4.3%+38.0%−31.8%−17.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported——$130.0K———$0Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.34 | — | — |
| Aug 2026 | −$0.47 | −$0.55 | −17.9% |
| May 2026 | −$0.44 | −$0.58 | −31.8% |
| Mar 2026 | −$0.50 | −$0.31 | +38.0% |
| Nov 2025 | −$0.47 | −$0.45 | +4.3% |
The latest year is open to everyone — the 34 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Sep 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 18, 2026 | −$0.34 | — | — | — | — | — | — |
| Aug 13, 2026 | −$0.47 | −$0.55 | −17.9% | — | $0 | — | −1.8% |
| May 14, 2026 | −$0.44 | −$0.58 | −31.8% | — | — | — | −4.7% |
| Mar 25, 2026 | −$0.50 | −$0.31 | +38.0% | — | — | — | −13.9% |
| Nov 13, 2025 | −$0.47 | −$0.45 | +4.3% | — | — | — | +4.3% |
The latest year is open to everyone — the 34 quarters behind it read with an account. Sign in | |||||||
| Aug 11, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 24, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 22, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Sep 29, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Dec 30, 2022 | |||||||
| Sep 29, 2022 | |||||||
| Jun 29, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Dec 30, 2021 | |||||||
| Sep 29, 2021 | |||||||
| Jun 29, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||